IHH Group Management

Executive Director and Chairman, IHH Healthcare
President, IMU and CEO, IMU Health
Tan Sri Dato' Dr Abu Bakar Bin Suleiman
Tan Sri Dato’ Dr Abu Bakar bin Suleiman brings to the table several decades of experience in the public and private healthcare sectors, particularly in the field of nephrology. He joined Malaysia’s Ministry of Health as Director of Medical Services in 1987 and became Director-General of Health in 1991. As a consultant nephrologist, he built up the nephrology renal transplantation and dialysis services at Hospital Kuala Lumpur and other Malaysian hospitals, while heading the Department of Nephrology at Hospital Kuala Lumpur. Tan Sri Abu Bakar is a fellow of the Royal Australasian College of Physicians as well as the Founding President of both the Malaysian Society of Nephrology and the Malaysian Society of Transplantation. He became President of the International Medical University in Kuala Lumpur in 2001 and continues to hold this position. Tan Sri Abu Bakar holds a MBBS from Monash University and a Master of Medicine (Internal Medicine) from the University of Singapore (now the National University of Singapore). He did his training in Nephrology at Georgetown University Hospital in Washington DC, as well as at Prince Henry’s Hospital in Melbourne. He also attended the Advanced Management Programme at Harvard Business School in 1991.
Tan Sri Abu Bakar is also a board member of CCM Duopharma Biotech Berhad and Medical Defence Malaysia Berhad.

Managing Director, IHH Healthcare
Dr Lim Cheok Peng
Dr Lim Cheok Peng has extensive experience both as a medical practitioner and in managing hospital businesses. He is one of the founding doctors of the Kuantan Specialist Centre, a 100-bed private hospital in Kuantan, Pahang. In 1985, Dr Lim practised internal medicine and cardiology at Mount Elizabeth Hospital and then went on to become a consultant to Parkway in 1987. In 2000, he took on the role of Managing Director of Parkway and was subsequently appointed as its Executive Vice Chairman in 2010. Dr Lim has been instrumental in expanding Parkway’s healthcare business in Singapore and abroad. In 2011, he joined IHH as Executive Director to lead its management team.
Dr Lim graduated from the University of Singapore with an MBBS in 1972 and obtained a Master of Medicine (Internal Medicine) from the same university in 1976. In 1977, he became a Member of the Royal College of Physicians of the United Kingdom and later became a Fellow of the Royal College of Physicians and Surgeons of Glasgow and Edinburgh.
Dr Lim is also a board member of Pantai Holdings Berhad, an indirect wholly owned subsidiary of the Company.

Executive Director, IHH Healthcare
Group CEO and Managing Director, Parkway Pantai Limited
Dr Tan See Leng
Dr Tan See Leng has over 20 years of experience in the healthcare industry. After founding a private primary healthcare group in Singapore, Dr Tan joined Parkway in 2004 as Chief Operating Officer of Mount Elizabeth Hospital. In 2006, he was appointed Senior Vice President, International Operations of Parkway before being seconded to Pantai as Chief Executive Officer (“CEO”) of the Hospitals Division. He held the position of Executive Vice President of Singapore and Malaysia Operations in 2009, until he became the Managing Director and CEO of Parkway in 2010. Following the restructuring of the Group in 2011, he assumed his current position as the Group CEO and Managing Director of Parkway Pantai Limited, an indirect wholly owned subsidiary of IHH. In 2012, he was appointed Executive Director of IHH.
An active member of various medical committees, Dr Tan currently serves as Vice President of the College of Family Physicians Singapore. He is also a Council Member of the Singapore-Guangdong Collaboration Council. He was reappointed Adjunct Assistant Professor of Duke-NUS Graduate Medical School Singapore, Office of Education for a three-year term until 2015.
Dr Tan holds an MBBS and a Master of Medicine (Family Medicine) from the National University of Singapore. He also has an MBA from the University of Chicago Graduate School of Business.
He is also a board member of Pantai Holdings Berhad, an indirect wholly owned subsidiary of the Company.

Executive Director, IHH Healthcare
Chairman and CEO, Acibadem Holding
Mehmet Ali Aydinlar
Mehmet Ali Aydinlar is the Chairman and Chief Executive Officer of the Acibadem Group. Mr Aydinlar is currently Chairman of the Turkish Accredited Hospitals Association. A certified public accountant-turned-entrepreneur, Mr Aydinlar has been recognised for his extensive experience in management and involvement in the healthcare sector since 1993. In 2006, he was named Male Entrepreneur of the Year in a survey conducted by Ekonomist Magazine and the “Business Executive of the Year” by Dünya Newspaper and Istanbul University’s School of Business Administration. He was also chosen to be “The Person who volunteers the most in contributing towards healthcare” by the Turkish Healthcare Volunteers Organisation. Mr Aydinlar was awarded “The Eminent Services Award of the Grand National Assembly of Turkey” in 2010.
Mr Aydinlar holds a Business Administration Degree from Galatasaray Economy and Management Business College.

Head of Corporate Services, IHH Healthcare
Executive Director of Corporate Services, Parkway Pantai Limited
Ahmad Shahizam Mohd Shariff
Ahmad Shahizam bin Mohd Shariff began his career in banking with HSBC Malaysia in 1994 and subsequently at ING Barings and Citigroup Salomon Smith Barney as an investment analyst. In 2004, he joined Khazanah Nasional Berhad (“Khazanah”) as Special Officer to the Managing Director and eventually assumed the position of Director, Investments responsible for Khazanah’s investments in the healthcare and power sectors. In 2008, Mr Ahmad Shahizam was appointed as an Alternate Director of Parkway Holdings Limited (“Parkway”) and Director of Pantai Holdings Berhad and IMU Health Sdn Bhd, before his appointment as Executive Director of Parkway in November 2010. He is also the Executive Director, Corporate Services of IHH and Executive Director, Corporate Services of Parkway Pantai Limited.
Mr Ahmad Shahizam holds a Bachelor of Laws (Hons) from the London School of Economics and Political Science, and a Master in Public Administration from Harvard University.
He is a board member of Pantai Holdings Berhad, an indirect wholly owned subsidiary of the Company.

Chief Financial Officer, IHH Healthcare
Group CFO, Parkway Pantai Limited
Tan See Haw
Tan See Haw held finance and audit positions at NL Petroleum (Far East) Pte Ltd and Price Waterhouse & Co. (now known as PricewaterhouseCoopers) between 1980 and 1986. Mr Tan then went on to hold key financial positions for major corporations such as Pepsi-Cola International (as Asia Division Financial Controller) from 1986 to 1994, and Asia Pacific Breweries Ltd (as Director of Group Finance) from 1994 to 1999. He subsequently assumed the position of Chief Financial Officer of Advanced Interconnect Technologies (“AIT”) in 1999. Following AIT’s acquisition by Unisem (M) Bhd (“Unisem”), Mr Tan became a Vice President of Unisem from 2007 to 2008.
In January 2009, Mr Tan was appointed as a Director of Parkway Trust Management, the manager of SGX-listed ParkwayLife REIT. On 5 January 2009, he assumed the position of Group Chief Financial Officer of Parkway Holdings Limited (“Parkway”), and was subsequently appointed as Group Chief Financial Officer of Parkway Pantai Limited following its acquisition of Parkway in April 2011. Mr Tan assumed his current position as Chief Financial Officer of IHH on 10 January 2013. Mr Tan graduated with a Bachelor Degree in Accountancy from the former Singapore University (now known as the National University of Singapore) in 1980. He is also a Fellow of the Institute of Certified Public Accountants of Singapore.

Head of Risk Management, IHH Healthcare
Noriyuki Sato
Noriyuki Sato collectively spent 33 years at Mitsui & Co Ltd in senior management roles both in Japan and in the company’s overseas operations in countries such as the United States, Canada, France and Algeria. Prior to joining IHH, Mr Sato was the General Manager of the Planning and Administrative Division in the Consumer Business Unit at Mitsui & Co. Ltd, where his main focus was to ensure that all of the Unit’s activities, including that of its medical and healthcare businesses, were conducted in accordance with Mitsui’s compliance and risk management framework. Mr Sato joined the IHH Group in August 2012 and today heads the Group’s Risk Management Division.
Mr Sato holds a B.A. from the Tokyo University of Foreign Studies and has completed an executive programme at the IMD Business School in Lausanne, Switzerland.